FDA Inspection 1013010 — Curia Massachusetts, Inc.

Curia Massachusetts, Inc. — FEI 3002951540

The FDA completed an inspection of Curia Massachusetts, Inc. on May 24, 2017 in Burlington, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Burlington, MA (United States)